Theravance Biopharma, Inc. (TBPH) — DEF 14A Filings
All DEF 14A filings from Theravance Biopharma, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Theravance Biopharma Files Definitive Proxy Statement
— Apr 10, 2025 Risk: low
Theravance Biopharma, Inc. filed its definitive proxy statement on April 10, 2025, for its annual meeting on May 19, 2025. The filing, under the 1934 Securities -
Theravance Biopharma, Inc. Announces 2024 Annual General Meeting Details
— Apr 5, 2024 Risk: low
Theravance Biopharma, Inc. (TBPH) filed a Proxy Statement (DEF 14A) with the SEC on April 5, 2024. The 2024 Annual General Meeting of Theravance Biopharma, Inc.
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX